Caring for Patients Using Alcohol During Pregnancy
Culturally Safe and Anti-Stigma Care
Fear of judgment, stigmatization, or involvement with child protection
services can discourage disclosure of alcohol use. This makes the
patient’s trust in the relationship the cornerstone of effective care.
In addition, Indigenous, racialized, and other marginalized communities may
have also experienced historical and ongoing systemic discrimination within
health and child protection services. These realities influence disclosure,
engagement, and trust. Cultural safety requires providers to actively reflect
on power dynamics, avoid stereotyping, use respectful language, and involve
community-informed supports where appropriate. Equity-focused care improves
both maternal and infant outcomes.
Clinical Tips
Build Trust
- Use open-ended language
- Normalize screening as routine care
- Avoid punitive approaches
- Validate incremental progress
Trauma-Informed Care
- Assume trauma may be present
- Prioritize safety and collaboration
- Offer choice and autonomy
- Ask about safety when appropriate
Cultural Safety
- Avoid assumptions or stereotyping
- Respect lived experience and patient priorities
- Engage community-informed supports when possible
Support increases disclosure; fear decreases it.
Treatment and Interventions for Alcohol Use During Pregnancy
Treating alcohol use in pregnancy requires more than advising cessation.
Alcohol Use Disorder (AUD) is a chronic, relapsing mental health condition
influenced by trauma, mental illness, and social determinants of health.
Pregnancy can be a powerful motivator for change, but it can also amplify
stress and vulnerability. Effective intervention integrates behavioral
counseling, mental health care, social supports, and when necessary
pharmacologic management. A recovery-oriented, non-punitive approach improves
engagement and outcomes. The
Centre for Addiction and Mental Health
has helpful information on alcohol treatment.
Clinical Pearls:
- Screen universally
- Avoid assumptions
- Small reductions matter
- Continued engagement
Alcohol Use Disorder is a Mental Health Condition
AUD is a chronic mental health condition characterized by impaired control
over alcohol use. Reframing AUD as a health condition reduces stigma and
shifts clinical conversations from blame to treatment. Patients with AUD often
experience shame and fear of child protection involvement, which can deter
disclosure. Recognizing co-occurring psychiatric conditions and trauma
histories is essential, as untreated mental health symptoms frequently drive
continued alcohol use. Integrated care models that address addiction, social
needs, and mental health concurrently are associated with improved maternal
and neonatal outcomes.
AUD often coexists with depression, anxiety, PTSD, trauma histories and social
instability.
Effective care integrates addiction treatment, mental health support, and
interventions that consider social determinants of health.
Pharmacologic Management
Pharmacologic management in pregnancy requires careful risk–benefit
analysis. Alcohol withdrawal can be life-threatening and must be managed
medically. Nutritional deficiencies are common in heavy alcohol use and
require correction. Relapse prevention pharmacotherapy is typically addressed
postpartum with specialist consultation. Clear communication about risks,
benefits, and alternatives is essential to shared decision-making.
The table below provides specific information about the pharmacologic
management of alcohol use during pregnancy and in the post-partum period. The
SOGC’s
Guideline No. 349-Substance Use in Pregnancy
provides additional information.
Pharmacologic Management of Alcohol Use During and After Pregnancy
|
Medication
|
Indication
|
Pregnancy Use
|
Breastfeeding Consideration
|
Comments
|
|
Benzodiazepines (e.g., lorazepam, diazepam)
|
Acute alcohol withdrawal
|
Use only in hospital settings; short-term, supervised use may be
necessary
|
May cause sedation or withdrawal in newborn; use with caution
|
Recommended only when risk of withdrawal outweighs fetal risks
|
|
Thiamine (Vitamin B1)
|
Prevent Wernicke-Korsakoff encephalopathy
|
Safe and recommended
|
Safe
|
Should be initiated before reducing alcohol intake
|
|
Multivitamin Supplementation
|
Nutritional support in chronic alcohol use
|
Safe and recommended
|
Safe
|
May include folate, iron, and other micronutrients
|
|
Naltrexone
|
Alcohol dependence (postpartum)
|
Recommended only when risk of withdrawal outweighs fetal risks
|
Safe in non-breastfeeding individuals; limited data for breastfeeding
|
Can support relapse prevention postpartum
|
|
Acamprosate
|
Alcohol abstinence maintenance
|
Recommended only when risk of withdrawal outweighs fetal risks
|
Used postpartum if no breastfeeding; renal dosing required; very
limited lactation data
|
May be considered for relapse prevention
|
|
SSRIs (e.g., sertraline)
|
Co-occurring depression/anxiety
|
Can be used with risk-benefit consideration
|
Generally compatible with breastfeeding
|
Preferred for perinatal depression; monitor infant for side effects
|